This study emphasizes that it would be important to investigate PD-1 and PD-L1/PD-L2 expression in plaques from PAD patients as well, to assess whether the local tissue expression of these immune checkpoints differ from our findings in blood. This evidence concerns the gene PDCD1 and peripheral arterial disease.